Susceptibility to diabetic neuropathy in patients with insulin dependent diabetes mellitus is associated with a polymorphism at the 5′ end of the aldose reductase gene

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 2, 1998, Pages 213-216

  Heesom, Angela E ^a   Millward, Ann ^a   Demaine, Andrew G ^a  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

Aldose reductase; Chromosome 7q35; Diabetic neuropathy; Insulin dependent diabetes mellitus

Indexed keywords

ALDEHYDE REDUCTASE; POLYOL;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CHROMOSOME 7Q; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE DURATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; ALDEHYDE REDUCTASE; ALLELES; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 7; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 0031920364     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.2.213     Document Type: Article

References (44)

1. Tesfaye S, Stevens LK, Stephenson JM, et al, and the EURODIAB IDDM Study Group. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM complications study. Diabetologia 1996;39:1377-84.
2. Greene DA, Sima AAF, Pfeifer MA, et al. Diabetic neuropathy. Ann Rev Med 1990;41:303-17.
3. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. Greene DA, Lattimer SA, Sirna AAF. Sorbitol, phosphoinositides and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987;316:599-606.
5. Dvornik D. Hyperglycaemia in the pathogenesis of diabetic complications In: Porte D, ed. Aldose reductase inhibition: an approach to the prevention of diabetic complications. New York: McGraw-Hill, 1987:7-151.
6. Cameron NE, Cotter MA, Low PA. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 1991;261:E1-8.
7. Dyck PJ. Hypoxic neuropathy: does hypoxia play a role in diabetic neuropathy? Neurology 1989;39:111-8.
8. Nishimura C, Lou MF, Kinoshita JH. Depletion of myo-inositol and amino acids in galactosemic neuropathy. J Neurochem 1987;49:290-5.
9. Boel E, Selmer J, Flodgaard HJ, et al. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise? J Diabetes Complications 1995;9:104-29.
10. van-Gerven JM, Tjon-A-Tsien AM. The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation. Drugs Ageing 1995;6:9-28.
11. Baynes JW. Role of oxidative stress in the development of complications of diabetes. Diabetes 1991;40:405-12.
12. Corbett JA, Tilton RG, Change K, et al. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 1992;41:552-6.
13. Williamson JR, Chang K, Frangos M, et al. Hyperglycaemic pseudohypoxia and diabetic complications. Diabetes 1993; 42:801-13.
14. Cameron NE, Cotter MA. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev 1994;10:189-224.
15. Yagihashi S, Yamagishi S-I, Wada R, et al. Galactosemic neuropathy in transgenic mice for human aldose reductase. Diabetologia 1996;45:56-9.
16. Bohren KM, Bullock B, Wermuth B, et al. The aldo-keto reductase superfamily. The cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem 1989;264:9547-51.
17. Chung S, LaMendola J. Cloning and sequence determination of human placental aldose reductase gene. J Biol Chem 1989;264:14775-7.
18. Nishimura C, Matsuura Y, Kokai Y, et al. Cloning and expression of human aldose reductase. J Biol Chem 1990;265:9788-92.
19. Graham A, Brown L, Hedge PJ, et al. Structure of the human aldose reductase gene. J Biol Chem 1991;266:6872-7.
20. Graham A, Heath P, Morten JEN, et al. The human aldose reductase gene maps to chromosome 7q35. Hum Genet 1991;86:509-14.
21. Bateman JB, Kojis T, Heinzmann C, et al. Mapping of aldose reductase gene sequences to human chromosomes 1, 3, 7, 9, 11, and 13. Genomics 1993;17:560-5.
22. Hibberd ML, Millward BA, Wong FS, et al. T-cell receptor constant β-chain polymorphisms and susceptibility to type I diabetes. Diabet Med 1992;9:929-33.
23. Patel A, Ratanachaiyavong S, Millward BA, et al. Polymorphisms of the aldose reductase locus (ALR2) and susceptibility to diabetic microvascular complications. Adv Exp Med Biol 1993;328:325-32.
24. Patel A, Hibberd ML, Millward BA, et al. Chromosome 7q35 and susceptibility to diabetic microvascular complications. J Diabet Complications 1996;10:62-7.
25. Heesom AE, Hibberd ML, Millward BA, et al. A polymorphism in the 5′end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes. Diabetes 1997;46:287-91.
26. Ko BC-B, Lam KS-L, Wat NM-S, Chung SS-M. An (A-C)n dinucleotide repeat polymorphic marker at the 5′end of the aldose reductase gene is associated with early-onset diabetic retinopathy in NIDDM patients. Diabetes 1995;44:727-32.
27. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-44.
28. Tiwari JL, Terasaki PI. The data and statistical analysis. In: Tiwari JL, Terasaki PI, eds. HLA and disease associations. New York: Springer Verlag, 1985:18-27.
29. Greene DA, Winegrad AI. Effects of acute experimental diabetes on composite energy metabolism in peripheral nerve axons and Schwann cells. Diabetes 1981;30:967-74.
30. Greene DA. Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function. Metabolism 1983;32: 118-25.
31. Greene DA, Lattimer SA. Impaired energy utilisation and Na-K-ATPase in diabetic peripheral nerve. Am J Physiol 1984;246:E311-8.
32. Tomlinson DR, Sidenius P, Larsen JR. Slow component-a of axonal transport, nerve myo-inositol and aldose reductase inhibition in streptozotocin-diabetic rats. Diabetes 1986;34: 398-402.
33. Finegold D, Lattimer S, Nolle S, Bernstein M, Greene DA. Polyol pathway activity and myo-inositol metabolism. Diabetes 1983;32:988-92.
34. Greene DA, Lattimer SA. Action of sorbitol in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Diabetes 1984;33:712-6.
35. Chakrabarti S, Sima AAF, Nakajima T, et al. Aldose reductase in the BB rat; isolation, immunological identification and localisation in the retina and peripheral nerve. Diabetologia 1987;30:244-51.
36. Sima AAF, Bril V, Nathanial V, et al. Regenration and repair of myelinated fibers in sural nerve biopsies from patients with diabetic neuropathy treated with an ARI. N Engl J Med 1988;319:548-55.
37. Nicolucci A, Hohman TC, Carinci F, et al. The efficacy of Tolrestsat in the treatment of diabetic peripheral neuropathy. Diabetes Care 1996;19:1091-6.
38. Dyck PJ, Zimmerman BR, Vilen TH, et al. Nerve glucose, fructose, sorbitol myo-inositol and fiber degenration and regeneration in diabetic neuropathy. N Engl J Med 1988;319:542-8.
39. Burg MB, Kador PF. Sorbitol, osmoregulation, and the complications of diabetes. J Clin Invest 1988;81:635-40.
40. Moriyama T, Garcia-Perez A, Burg MB. Osmotic regulation of aldose reductase protein synthesis in renal medullary cells. J Biol Chem 1989;264:16810-4.
41. Moo Kwon H, Yamauchi A, Uchida S, et al. Renal Na-myoinositol cotransporter mRNA expression in Xenopus oocytes: regulation by hypertonicity. Am J Physiol 1991; 260:F258-63.
42. Hamada Y, Kitoh R, Raskin P. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients. Diabetes 1991;40:1233-10.
43. Hamada Y, Kitoh R, Raskin P. Association of erythrocyte aldose reductase activity with diabetic complications in type 1 diabetes mellitus. Diabet Med 1993;10:33-8.
44. Ko BC-B, Reupp B, Bohren KM, et al. Identification and characterisation of mulitiple osmotic response sequences in the human aldose reductase gene. J Biol Chem 1997;272: 16431-7.